Ankur Dhingra Summit Therapeutics Inc. (SMMT) insider trading activity

SMMT Quotes by TradingView

Ankur Dhingra is Chief Financial Officer of Summit Therapeutics Inc.. Currently has a direct ownership of 38,057 shares of SMMT, which is worth approximately $803,002. The most recent transaction as insider was on Aug 16, 2022, when has been sold 11,557 shares (Common Stock) at a price of $0.97 per share, resulting in proceeds of $11,210. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.1K
0% 3M change
0% 12M change
Total Value Held $803,002

Ankur Dhingra Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2022
BUY
Open market or private purchase
$11,210 $0.97 p/Share
11,557 Added 23.29%
38,057 Common Stock

Also insider at

CDNA
CareDx, Inc. Healthcare
Chief Financial Officer
ILMN
ILLUMINA, INC. Healthcare
SVP, Chief Financial Officer
AD

Ankur Dhingra

Chief Financial Officer
Menlo Park, CA

Track Institutional and Insider Activities on SMMT

Follow Summit Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SMMT shares.

Notify only if

Insider Trading

Get notified when an Summit Therapeutics Inc. insider buys or sells SMMT shares.

Notify only if

News

Receive news related to Summit Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SMMT